Literature DB >> 14767743

Rhabdomyolysis associated with omeprazole.

Miho Nozaki, Tsuyoshi Suzuki, Masanori Hirano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14767743     DOI： 10.1007/s00535-003-1231-7

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  8 in total

Review 1.  Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?

Authors:  David W J Clark; Johanna Strandell
Journal:  Eur J Clin Pharmacol       Date:  2006-04-22       Impact factor: 2.953

2.  Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database.

Authors:  Alice Capogrosso Sansone; Irma Convertino; Maria Teresa Galiulo; Stefano Salvadori; Stefania Pieroni; Tamara Knezevic; Stefania Mantarro; Alessandra Marino; Manfred Hauben; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2017-10       Impact factor: 5.606

3.  Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis.

Authors:  Santiago Vilar; Rave Harpaz; Herbert S Chase; Stefano Costanzi; Raul Rabadan; Carol Friedman
Journal:  J Am Med Inform Assoc       Date:  2011-09-21       Impact factor: 4.497

Review 4.  Proton Pump Inhibitors and Risk of Rhabdomyolysis.

Authors:  Scott J Duncan; Colin W Howden
Journal:  Drug Saf       Date:  2017-01       Impact factor: 5.606

5.  Statin-associated polymyositis following omeprazole treatment.

Authors:  Rajan Kanth; Milind S Shah; Rafael Medina Flores
Journal:  Clin Med Res       Date:  2013-04-11

Review 6.  Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori.

Authors:  Oren Cohen; Garrett Locketz; Alon Y Hershko; Alexander Gorshtein; Yair Levy
Journal:  Rheumatol Int       Date:  2015-07-26       Impact factor: 2.631

7.  Omeprazole-associated rhabdomyolysis.

Authors:  Kumiko Tanaka; Taka-Aki Nakada; Ryuzo Abe; Sakae Itoga; Fumio Nomura; Shigeto Oda
Journal:  Crit Care       Date:  2014-07-24       Impact factor: 9.097

8.  Rhabdomyolysis associated with single-dose intravenous esomeprazole administration: A case report.

Authors:  Dae-Hong Jeon; Yire Kim; Min Jeong Kim; Hyun Seop Cho; Eun Jin Bae; Se-Ho Chang; Dong Jun Park
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.